ISMRM 2019 in Montreal
Cubresa is pleased to announce that it will have its clinical BrainPET demo unit on display at the ISMRM 2019 Annual Meeting & Exhibition in Montreal from May 12th to the 16th. Please come by booth 1011 to learn more about this investigational device, and meet BrainPET’s Product Manager, Manjari Murthy, to discuss its
Cubresa selects distributor for preclinical line of PET inserts in China
Winnipeg, MB – February 25th, 2019 – Cubresa Inc., a world leader in PET inserts for MRI, has selected a Chinese distributor for its NuPET™ preclinical imaging product line. Cubresa is pleased to announce that it has signed an agreement with Worldwide Technology (S.H.) Co., Ltd. (WAD), a Shanghai-based distributor who specializes in the sale
Cubresa Developing BrainPET Insert Through Joint Venture in China
Winnipeg, MB – January 29th, 2019 – Cubresa Inc., a world leader in PET inserts for MRI, is expanding into the clinical marketplace with the announcement of a joint venture in Hefei, China. Together with the GaoXin Group and private investors, Cubresa has formed the Sino-Canadian Health Engineering Research Institute (SCHERI), based in Hefei, Anhui
NuPET Seminar at Northwestern University
10 am on Friday, May 15th in the Searle Seminar Room at the Robert H. Lurie Medical Research Center Cubresa held a seminar on Simultaneous Molecular & Functional Imaging with the Cubresa NuPET™ MR-compatible preclinical PET scanner at Northwestern University at 10 am on Friday, May 12th in the Searle Seminar Room at the Robert H. Lurie
ISMRM 2017 in Honolulu
Come see Cubresa’s NuPET™ in Booth 125 at the ISMRM 2017 Annual Meeting & Exhibition in Honolulu Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging We certainly enjoyed our time at this year’s International Society for Magnetic Resonance in Medicine in Honolulu, April 22 to 27, 2017 where we showcased our NuPET™ in-bore PET scanner for existing pre-clinical
EMIM 2017 in Cologne
Thank you for coming to see Cubresa’s NuPET™ at the EMIM 2017 Meeting & Exhibition in Cologne Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging This year’s European Molecular Imaging Meeting at Hörsaalgebäude University in Cologne, April 5 to 7, 2017 was a very successful showcase for our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. The
Cubresa SPECT Scanner Used for Evaluation of Alzheimer’s Disease Molecular Label in vivo
Cubresa’s SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer’s Disease patients follows the known distribution of the enzyme in animal models of the disease. Winnipeg, MB – November 22, 2016 – Cubresa Inc., a medical
Cubresa Moves to Larger Facility in Winnipeg
Cubresa’s new, larger headquarters will open for business at the following address on Tuesday September 6, 2016: Cubresa Inc. 801 Berry Street Winnipeg, MB R3H 0S7 Our telephone and facsimile numbers, as well as our e-mail addresses and web address, will remain the same. We look forward to fully utilizing our improved headquarters for research &
Preclinical PET Scanner for Simultaneous PET/MRI Installed at the University of Arizona Could Contribute to Improved Tumor Assessment
Dual-modality approach being developed by the University of Arizona uses Cubresa’s NuPET™ PET scanner and a dynamic MRI technique to more fully characterize cancerous tumors. Winnipeg, MB – September 1, 2016 – Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced the successful installation of their compact PET scanner called NuPET™ for
BIOTIC and Cubresa continue successful partnership with PET scanner testing
Halifax, NS – August 5, 2016 – BIOTIC (Biomedical Translational Imaging Centre), the advanced imaging center at the IWK Health Centre, has been chosen as the first research facility to test a new preclinical PET (Positron Emission Tomography) scanner. Cubresa, a medical imaging company that develops and markets nuclear imaging systems, has developed NuPET™, a
Cubresa Booth 207 at WMIC in New York
Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York UPDATE: Congratulations to Patrick Chow of Bristol-Myers Squibb, on winning our custom-engraved Apple® iPad™ Pro in the booth on Saturday. Dr. Chow was selected at random from attendees who participated in our survey. Bookmark this page[1]To bookmark this page, press the Ctrl (PCs)
Imaging cloak patent could enable more accurate 3D medical imaging
Winnipeg, MB – July 13, 2016 – Instead of a cloak of invisibility hiding a person in television and movies, a new method that describes mounting many imaging sensors underneath a flexible substrate could reveal tumors within humans or animals. Cubresa Inc., a medical imaging company that develops and markets nuclear imaging systems, today announced
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Products
Clinical:
Preclinical:
Contact
Request more information